Dale Stafford
Partner,
About Dale
Expertise
Dale Stafford is a member of our Mergers & Acquisitions and Healthcare and Life Sciences practices. He has more than 20 years of management consulting experience, advising leading companies on their biggest challenges and opportunities.
Dale has led successful merger integrations in a variety of industries, including medical technology, pharmaceuticals, airlines, transportation, professional services, wholesale distribution, telecommunications, cable, software and consumer products. In addition, he has extensive experience developing growth strategies to help providers, insurers, life sciences, and healthcare technology companies outperform.
Prior to joining Bain, Dale worked in strategy at Coca-Cola Enterprises. He started his career as a designer/developer of software for healthcare companies.
Dale studied business strategy at the Leipzig School of Management in Germany and earned an MBA at Emory University, where he was a Woodruff Scholar. He graduated summa cum laude from the University of Mississippi with a Bachelor of Science in mathematics.
Bain partner Dale Stafford discusses "Integrating cultures after a merger."
Recent Insights
- “M&A Midyear Report 2024: Dealmakers Mine Multiple Sources of Value,” Report, lipiec 2024
- “How Companies Got So Good at M&A ,” Brief, kwiecień 2024
- “Key Insights from Bain’s 2024 M&A Report,” Webinar, luty 2024
- “Regulation and M&A: How Scrutiny Raises the Bar for Acquirers ,” M&A Report, styczeń 2024, Report
- “Looking Back at M&A in 2023: Who Wins in a Down Year?,” M&A Report, styczeń 2024, Report
In the News
- “Health-care companies are on a deal spree and aren't likely to stop anytime soon,” CNBC, kwiecień 2018, CNBC
- “China Moves a Step Forward in Its Quest for Food Security ,” New York Times, kwiecień 2017, New York Times
- “Dale Stafford on the State of M&A in Healthcare,” Bloomberg, marzec 2017, Bloomberg
- “When mergers fail because of clashing work culture,” Marketplace, maj 2016, Marketplace
- “M&A Boom Goes Bust on Regulatory Uncertainty,” Bloomberg TV, maj 2016, Bloomberg TV